Liofilchem™ MTS™ Cefotaxime/Cefotaxime + Clavulanic Acid (4 μg/mL) [CTX/CTL] 0.25-16/0.016-1 μg/mL

Description

• Ready to use
• No preparation or dilution of antimicrobial agent is required
• Simply place on an inoculated agar plate and incubate MIC testing for a wide range of agents and against many organisms can be done on request and at short notice Synergy Testing: can be crossed for evaluating a critical assay such as the in vitro combination of antibiotics Rapid and Efficient: easy to set up
• Full range of MIC testing of 6 agents on a large plate takes no more than 5 minutes Solid Medium: Growth of organisms on agar better mimics in vitro conditions
• It is easy to visualize hetero-resistant variants in a population and to detect mixed cultures and contamination Inoculum Tolerant, Macro.Method: a stable gradient technique that is inoculum tolerant (changes in inoculum do not affect the MIC results for a susceptible strain), thus it can be used in a macro-format with heavier inoculum and a richer media to maximize the detection of low-level and hetero-resistance Easy to Handle: The package is small and light weigh
• Required storage space is minimal Wide MIC Range: spans across 15 dilutions fulfilling pharmacokinetic needs, varying susceptibility of many organism groups, and covers different MIC breakpoints used in different countries as recommended by various reference or expert groups Easy to Learn: Minimal training is required for clinical microbiology personnel No equipment is required for use Easy for New Agents MIC Equivalent to Reference Values Improved MIC Precision Flexible Media Choice: can be used as a quality control tool for checking different AST media, brand to brand and batch to batch Robust Technique Generates quantitative MIC values that are needed to guide therapy selection for the individual patient - choice, dose and regimen Can be used for Fastidious and Slow Growers Can be used to directly test positive blood cultures, CSF and sputum from cystic fibrosis patients and bronchial aspirates from VAP patients
• The extra day saved by testing the specimen directly can have significant impact in therapy management, patient care and hospital cost savings